Riviciclib hydrochloride

Products

Inquiry

Cat. No.: IBDI-431945

Riviciclib hydrochloride (P276-00) is a potent cyclin-dependent kinase (CDK) inhibitor, which inhibits CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively. Riviciclib hydrochloride (P276-00) shows antitumor activity on cisplatin-resistant cells.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	CDK \| Apoptosis
Molecular Weight	438.30
Appearance	Solid
Synonyms	P276-00
SMILES	[H]Cl.O=C1C=C(C2=CC=CC=C2Cl)OC3=C([[email protected]@H]4CCN(C)[[email protected]]4CO)C(O)=CC(O)=C31
Purity	99.01%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.